Tandem Diabetes Care Inc (NASDAQ: TNDM) on Monday, plunged -3.16% from the previous trading day, before settling in for the closing price of $16.78. Within the past 52 weeks, TNDM’s price has moved between $15.75 and $48.24.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -28.23%. The company achieved an average annual earnings per share of 5.91%. With a float of $65.97 million, this company’s outstanding shares have now reached $66.57 million.
Let’s determine the extent of company efficiency that accounts for 2650 employees. In terms of profitability, gross margin is 46.57%, operating margin of -16.18%, and the pretax margin is -15.82%.
Tandem Diabetes Care Inc (TNDM) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Tandem Diabetes Care Inc is 0.96%, while institutional ownership is 110.47%. The most recent insider transaction that took place on Mar 07 ’25, was worth 190,966. In this transaction EVP & Chief Operating Officer of this company bought 10,538 shares at a rate of $18.12, taking the stock ownership to the 10,538 shares. Before that another transaction happened on Nov 21 ’24, when Company’s Director sold 30,000 for $31.38, making the entire transaction worth $941,400. This insider now owns 165,190 shares in total.
Tandem Diabetes Care Inc (TNDM) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 5.91% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 71.00% during the next five years compared to -28.23% drop over the previous five years of trading.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
Tandem Diabetes Care Inc (TNDM) is currently performing well based on its current performance indicators. A quick ratio of 1.81 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.78, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -0.65 in one year’s time.
Technical Analysis of Tandem Diabetes Care Inc (TNDM)
Looking closely at Tandem Diabetes Care Inc (NASDAQ: TNDM), its last 5-days average volume was 2.32 million, which is a jump from its year-to-date volume of 1.56 million. As of the previous 9 days, the stock’s Stochastic %D was 12.27%.
During the past 100 days, Tandem Diabetes Care Inc’s (TNDM) raw stochastic average was set at 2.58%, which indicates a significant decrease from 8.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 33.50% in the past 14 days, which was lower than the 90.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $20.40, while its 200-day Moving Average is $28.28. However, in the short run, Tandem Diabetes Care Inc’s stock first resistance to watch stands at $16.69. Second resistance stands at $17.14. The third major resistance level sits at $17.58. If the price goes on to break the first support level at $15.80, it is likely to go to the next support level at $15.36. Now, if the price goes above the second support level, the third support stands at $14.91.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Key Stats
Market capitalization of the company is 1.08 billion based on 66,607K outstanding shares. Right now, sales total 940,200 K and income totals -96,030 K. The company made 234,420 K in profit during its latest quarter, and -130,560 K in sales during its previous quarter.
